Feeley Kevin, CFO, reported an open-market or private sale at GeneDx Holdings Corp. involving 372.000000 shares for an estimated $31188.11. Reported holdings after the transaction were 40299.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
CHIEF FINANCIAL OFFICER
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax…
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.71 to $83.84 per share, inclusive. The Reporting Person undertake…
Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 40,299 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person…
6.25% of the total award vested or vests quarterly, with the first tranche vested on December 1, 2022, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSU…
0 other filings
0 recent txs